Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Roche Products Limited
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 13/09/2011
PIL Neorecormon Multidose Powder and Solvent for Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 13/06/2011 and displayed until 13/09/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 25/03/2011 and displayed until 13/06/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 16/12/2008 and displayed until 25/03/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 10/11/2008 and displayed until 16/12/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 14/04/2008 and displayed until 10/11/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 12/03/2008 and displayed until 14/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 23/08/2007 and displayed until 12/03/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
Updated on 14/02/2007 and displayed until 23/08/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
Updated on 09/01/2006 and displayed until 14/02/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to Marketing Authorisation Holder
  • Change to date of revision
Updated on 06/01/2006 and displayed until 09/01/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to Marketing Authorisation Holder
  • Change to date of revision
Updated on 01/08/2005 and displayed until 06/01/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to how the medicine works
  • Change to Further Information section
Updated on 31/03/2005 and displayed until 01/08/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 18/11/2003 and displayed until 31/03/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 19/08/2003 and displayed until 18/11/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 08/04/2003 and displayed until 19/08/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  epoetin beta